Dual antithrombotic therapy and gastroprotection in atrial fibrillation: an observational primary care study

BACKGROUND: Patients with both atrial fibrillation (AF) and cardiovascular disease (CVD) may receive dual antithrombotic therapy (DAT) with both an anticoagulant and ≥1 antiplatelet agents. Avoiding prolonged duration of DAT and use of gastroprotective therapies reduces bleeding risk. AIM: To descri...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Charis Xuan, Robson, John, Williams, Crystal, Carvalho, Chris, Rison, Stuart, Raisi-Estabragh, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904777/
https://www.ncbi.nlm.nih.gov/pubmed/36028299
http://dx.doi.org/10.3399/BJGPO.2022.0048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904777/
https://www.ncbi.nlm.nih.gov/pubmed/36028299
http://dx.doi.org/10.3399/BJGPO.2022.0048

Ejemplares similares